Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

(Nanowerk News) Researchers from more than 50 international institutions have launched Open Problems a collaborative open-source platform to benchmark, improve, and run competitions for computational ...

This Research Topic is the second volume of the “Unraveling Breast Cancer Complexity: Insights from Single-Cell Sequencing and Spatial Transcriptomics” ...

The discovery of G protein-coupled receptor (GPCR) heteromers has revealed a new level of complexity in their functional characteristics. This review explores a variety of methodologies and live cell ...

John M. Archibald is in the Department of Biochemistry and Molecular Biology, Dalhousie University, Halifax, Nova Scotia B3H 4H7, Canada, and also at the Institute for Comparative Genomics, Dalhousie ...